4-aminopyridine has been researched along with Central Nervous System Disease in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In five rats with demyelination, slowed conduction velocity through the lesion was partially reversed at dose levels of 5." | 1.27 | Effects of 4-aminopyridine in experimental CNS demyelination. ( Kaji, R; Sumner, AJ, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghalehshahi, HG | 1 |
| Balalaie, S | 1 |
| Sohbati, HR | 1 |
| Azizian, H | 1 |
| Alavijeh, MS | 1 |
| Kaji, R | 1 |
| Sumner, AJ | 1 |
2 other studies available for 4-aminopyridine and Central Nervous System Disease
| Article | Year |
|---|---|
Synthesis, CYP 450 evaluation, and docking simulation of novel 4-aminopyridine and coumarin derivatives.
Topics: 4-Aminopyridine; Central Nervous System Diseases; Coumarins; Cytochrome P-450 Enzyme System; Drug Di | 2019 |
Effects of 4-aminopyridine in experimental CNS demyelination.
Topics: 4-Aminopyridine; Aminopyridines; Animals; Central Nervous System Diseases; Demyelinating Diseases; D | 1988 |